ORPHAZYME A/S - ADR (ORPH) Stock Balance Sheet
NASDAQ:ORPH - Nasdaq - ADR
| MRQ (2021-6-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 334.18M | 726.93M | 123.59M | 394.71M | 631.74M | |||
| Receivables | 33.90M | 5.50M | 5.50M | 5.50M | 5.50M | |||
| Other Current Assets | 35.61M | 51.23M | 19.14M | 23.18M | 10.72M | |||
| Total Current Assets | 403.69M | 783.66M | 148.22M | 423.38M | 647.95M | |||
| Non-Current Assets | ||||||||
| PPE Net | 13.93M | 19.55M | 17.59M | 1.94M | 1.85M | |||
| Intangibles | 2.19M | 12.45M | 10.54M | 10.74M | 9.85M | |||
| Other Non-Current Assets | 2.71M | 4.08M | 1.65M | 2.53M | 410.00K | |||
| Total Non-Current Assets | 24.34M | 38.83M | 32.53M | 17.96M | 14.86M | |||
| TOTAL ASSETS | 428.03M | 822.49M | 180.75M | 441.35M | 662.82M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 35.99M | 37.01M | 12.81M | N/A | N/A | |||
| Accrued Expenses | N/A | 50.49M | 16.28M | 8.68M | 6.25M | |||
| Accounts Payable | 98.98M | 72.14M | 32.39M | 42.18M | 40.23M | |||
| Other Current Liabilities | 88.69M | 7.00M | 4.51M | 2.13M | 632.00K | |||
| Total Current Liabilities | 223.66M | 166.63M | 65.99M | 52.99M | 47.12M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 22.60M | 33.71M | 61.42M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 15.01M | 1.63M | 378.00K | 105.00K | 0.00 | |||
| Total Non-Current Liabilities | 37.61M | 35.34M | 61.80M | 105.00K | 0.00 | |||
| TOTAL LIABILITIES | 261.27M | 201.97M | 127.78M | 53.10M | 47.12M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.95B | -1.50B | -891.14M | -555.75M | -328.25M | |||
| Additional Paid In Capital | 2.08B | 2.08B | 924.02M | 924.02M | 924.02M | |||
| Common Shares | 34.95M | 34.70M | 19.98M | 19.94M | 19.93M | |||
| Other Shareholders' Equity | 790.00K | 714.00K | 109.00K | 42.00K | 0.00 | |||
| Shares Outstanding | 34.95M | 34.70M | 19.98M | 19.94M | 19.94M | |||
| Tangible Book Value per Share | 4.71 | 17.52 | 2.12 | 18.93 | 30.38 | |||
| Total Shareholders' Equity | 166.76M | 620.52M | 52.97M | 388.25M | 615.70M | |||
| TOTAL LIABILITIES AND EQUITY | 428.03M | 822.49M | 180.75M | 441.35M | 662.82M | |||
| Statistics | ||||||||
| Debt/Equity | 0.14 | 0.05 | 1.16 | N/A | N/A | |||
| Current Ratio | 1.80 | 4.70 | 2.25 | 7.99 | 13.75 | |||
| Return On Assets (ROA) | -197.56% | -76.99% | -186.72% | -52.02% | -19.04% | |||
| Return On Equity (ROE) | -507.08% | -102.05% | -637.16% | -59.14% | -20.50% | |||
All data in DKK , ROIC based on taxRate of 0.21